Advanced Size-Exclusion Chromatography: Focusing on Improved Column Lifetime and the Benefits of an Inert Surface

RECORD | Already taken place We, 9.11.2022
In this webinar, Dr. Helen Whitby will explain the foundation of size-exclusion theory and offer method development insight to select the proper column chemistry and improve upon traditional methods.
SelectScience: Advanced Size-Exclusion Chromatography: Focusing on Improved Column Lifetime and the Benefits of an Inert Surface
SelectScience: Advanced Size-Exclusion Chromatography: Focusing on Improved Column Lifetime and the Benefits of an Inert Surface

Size-exclusion chromatography (SEC) is a well-established analytical method for quantitative and qualitative aggregate analysis of monoclonal antibodies (mAbs) and other related biotherapeutics. To get accurate results and maintain column lifetime, recent advancements, such as diol-link size exclusion columns, make it easier to implement and maintain new SEC methods.

In this webinar, Dr. Helen Whitby will explain the foundation of size-exclusion theory and offer method development insight to select the proper column chemistry and improve upon traditional methods.

Key learning objectives
  • Discover the fundamentals of SEC
  • Understand particle characteristics and what this means to your separation
  • Learn how to structure your method for maximum resolution
  • Master robust method development
Who should attend?
  • Scientists with an interest in updating a platform or legacy SEC
  • Scientists looking to improve their SEC
  • Scientists who want to learn more about column selection and improve column lifetimes

Presenter: Dr. Helen Whitby, PhD (Senior Product Manager – Biopharma, Phenomenex)

Helen has a Ph.D. in synthetic, organic, and analytical chemistry from the University of Manchester, United Kingdom, and has worked at Phenomenex for the last 15 years specializing in HPLC and Bioseparations.

Presenter: Georgina Wynne Hughes (Editorial Team, SelectScience)

Georgina studied at Birmingham University where she gained a BSc in Biomedical Science, and an MSc by Research in Cancer and Genomic Sciences, which focused on defective autophagy in rare neurodegenerative diseases. As a member of the Editorial team, she now plays an integral role in shaping the content on SelectScience.

SelectScience
LinkedIn Logo